Daniel Trencher - 10 May 2021 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
SVP Corporate Strategy
Signature
/s/ Adam C. Vandervoort, attorney-in-fact
Issuer symbol
TDOC
Transactions as of
10 May 2021
Net transactions value
-$259,592
Form type
4
Filing time
11 May 2021, 16:13:40 UTC
Next filing
11 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise $40,408 +1,812 +7.7% $22.30 25,486 10 May 2021 Direct F1
transaction TDOC Common Stock Sale $300,000 -2,000 -7.8% $150.00* 23,486 10 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Employee Stock Option (right to buy) Options Exercise $0 -1,812 -5.8% $0.000000 29,430 10 May 2021 Common Stock 1,812 $22.30 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 28, 2020.
F2 The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vested in 36 equal monthly installments thereafter.